Biotech By Kate Sheridan Graduate students launch an entrepreneurship program to bring new faces to biotech
Health By Gideon Gil ‘I can still feel it’: Groundbreaking arm amputation surgery makes a ‘phantom’ hand seem real
Biotech By Damian Garde and Adam Feuerstein Biogen admits Aduhelm launch ‘slower than we anticipated’
A STAT Investigation By Eric Boodman Cement Head’s last fight: He was denied parole six times — until he was about to become a Covid-19 statistic
Health By Elizabeth Cooney Long after the fire of a Covid-19 infection, mental and neurological effects can still smolder
Health By Matthew Herper and Damian Garde First data for Moderna Covid-19 vaccine show it spurs an immune response
Health By Sharon Begley Racial bias skews algorithms widely used to guide care from heart surgery to birth, study finds
Biotech By Helen Branswell Vaccine experts say Moderna didn’t produce data critical to assessing Covid-19 vaccine
Biotech By Jon Chesto — Boston Globe As scientific labs replace offices, pushback is mounting from wary neighbors
By Jeremy C. Fox — Boston Globe MIT professor sues after he was forced to resign from institute following sexual harassment allegations
Health By Megan Molteni Sex of the fetus influences the mother’s response to Covid-19 infection, new research shows
Health Tech By Isabella Cueto A new surgical robot is smaller, nimbler, and cheaper, its maker claims. But will it be better for patients?
Biotech By Kate Sheridan Graduate students launch an entrepreneurship program to bring new faces to biotech
Health By Gideon Gil ‘I can still feel it’: Groundbreaking arm amputation surgery makes a ‘phantom’ hand seem real
Biotech By Damian Garde and Adam Feuerstein Biogen admits Aduhelm launch ‘slower than we anticipated’
Biotech By Jon Chesto — Boston Globe Boston Scientific completes $1 billion acquisition of Israeli firm
The Pharmalot View By Ed Silverman ‘Remember her as the badass she was’: ALS patient who died should force Biogen, others to anticipate expanded access issues
Biotech By Anissa Gardizy — Boston Globe Adagio raises $300 million in IPO, looks to advance Covid-19 antibody therapy
Biotech By Kate Sheridan Amylyx is breaking all of biotech’s unwritten rules — and still raising impressive sums
Health By Eric Boodman With fewer than 400 progeria patients worldwide, testing a CRISPR cure will be challenging
Exclusive By Erin Brodwin In a new role at health tech startup Maven, Neel Shah wants to make sure pregnant people aren’t ‘lost’
Biotech By Felice J. Freyer — Boston Globe What’s next for the new Alzheimer’s drug? Lots of thorny issues ahead
Biotech By Adam Feuerstein German drug maker MorphoSys to buy Constellation Pharma in $1.7 billion deal
Health By Andrew Joseph Aiming to diversify science journalism, STAT creates fellowship named for reporter Sharon Begley
Health By Rebecca Ostriker and Andrea Estes — The Boston Globe The inside story of a Covid-19 outbreak that killed 76 veterans at a Massachusetts senior-care center
Biotech By Jonathan Saltzman — Boston Globe Atlas Venture launches another biotech to tackle vision loss
Health Tech By Mario Aguilar Inside Pear’s ambitious plan to become the most dominant player in digital therapeutics
Biotech By Jonathan Saltzman — Boston Globe Moderna’s CEO says he ‘didn’t lose a minute of sleep’ over potential waiver of vaccine patents
Biotech By Anissa Gardizy — Boston Globe Dyno raises $100 million to bring artificial intelligence to gene therapy
Biotech By Megan Molteni Beam Therapeutics unveils new CRISPR base editing tool to target the sickle cell mutation
Biotech By Anissa Gardizy — Boston Globe Adagio raises $336 million to advance Covid-19 antibody treatment